Aurora Cannabis Bolsters Leadership with Pharmaceutical Veteran Simona King as CFO

Aurora Cannabis, a prominent player in the Canadian cannabis industry, has announced the appointment of Simona King, a seasoned executive from multinational pharmaceutical giant Bristol Myers Squibb, as its new Chief Financial Officer. King succeeds Glen Ibbott, one of the longest-serving executives at Aurora, who has decided to step down from his role “to pursue new opportunities.” Despite his departure, Ibbott will continue to serve in an advisory capacity.

The appointment comes as Aurora Cannabis completes its share consolidation, a strategic move aimed at enhancing compliance with Nasdaq’s minimum bid price requirement and facilitating broader access to institutional investors.

In recent years, Aurora has intensified its focus on the medical cannabis sector, aligning with CEO Miguel Martin’s vision since late 2020. The company’s strategic initiatives, including the appointment of Theresa Firestone to its board, reflect its commitment to leveraging pharmaceutical expertise and fostering strategic partnerships to drive growth and innovation.

Aurora CEO Miguel Martin expressed gratitude for Ibbott’s invaluable contributions to the company’s growth and transformation into a leading medical cannabis enterprise. Under Ibbott’s leadership since 2017, Aurora has solidified its position in the medical cannabis market, benefiting from his dedication and vision.

Have you read?
Revealed: Highest-paid college football coaches, 2024.
Revealed: These are the Deadliest Cars you can drive in the US, 2024.
Revealed: Words that weren’t in use before the 1990s but are now commonly used.
Ranked: Countries with the lowest petrol prices, 2024.
Revealed: The World’s Safest Airlines To Fly In 2024.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name